Clinical trials · Illinois
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 clinical trials in Illinois
We’re tracking 5 recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies with a site in Illinois — including Phase 1 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies in Illinois
- NCT05136196RecruitingPhase 2
Cabozantinib plus nivolumab for advanced melanoma or head-neck cancer
This trial tests whether combining two immunotherapy medicines—cabozantinib and nivolumab—can shrink advanced melanoma or certain head-and-neck squamous cell cancers. It is mainly for people whose cancer has grown after prior PD-1 treatment.
Aurora, IllinoisAges 18 years+ - NCT07195734RecruitingPhase 2
Adding chemo or immunotherapy before surgery for advanced head and neck cancer
This trial tests whether giving chemotherapy or chemotherapy plus immunotherapy before surgery can improve outcomes for people with advanced head and neck cancer that has come back or not gone away after prior treatment.
Chicago, IllinoisAges 18 years+ - NCT05172245RecruitingPhase 1
Testing a new drug added to chemoradiation for head and neck cancer
This study tests whether adding a new targeted drug called ipatasertib to standard chemoradiation can improve treatment for people with locally advanced head and neck cancer. Ipatasertib may help block a protein that helps cancer grow, possibly making the standard therapy more effective.
Chicago, IllinoisAges 18 years+ - NCT06532279RecruitingPhase 2
Testing BMX-001 with chemoradiation for head and neck cancer
This trial tests whether adding BMX-001 (a drug that may protect healthy tissues) to standard chemoradiation can reduce side effects and improve outcomes for people with head and neck cancer. It's a randomized study, so you would have a 50/50 chance of getting BMX-001 or a placebo.
Bloomington, IllinoisAges 18 years+ - NCT02734537RecruitingPhase 2
Radiation with or without cisplatin after head and neck surgery
This trial studies whether adding cisplatin (a chemotherapy medicine) to radiation therapy helps people with stage III–IVA squamous cell cancer of the head and neck after they’ve had surgery. It’s meant to lower the risk of the cancer coming back.
Alton, IllinoisAges 18 years+
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trials by city in Illinois
Where these studies are running in Illinois
Institutions with a site for the recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies listed above.
- Northwestern University · 5 studies
- Carle at The Riverfront · 4 studies
- Carle Cancer Center · 4 studies
- Carle Physician Group-Effingham · 4 studies
- Carle Physician Group-Mattoon/Charleston · 4 studies
- Illinois CancerCare - Washington · 3 studies
- Illinois CancerCare-Bloomington · 3 studies
- Illinois CancerCare-Canton · 3 studies
What taking part in a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trials in other states
Common questions
- Are there stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 clinical trials in Illinois?
- Yes. We're currently tracking 5 recruiting stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies with a site in Illinois, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 study in Illinois?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Illinois to take part?
- Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New stage iii oropharyngeal (p16-negative) carcinoma ajcc v8 studies open in Illinois regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.